Home | Drugs Approvals and Trials

Drugs Approvals and Trials

New clinical trial rules boost patient benefit in Europe

The European Parliament has today (Thursday) approved a new set of rules governing clinical trials that will help our understanding of disease, ...

Time, trust and transparency keys to minority biospecimen collection

UC Davis leads study on strategies to even the clinical research playing field ...

FDA approves Impavido to treat tropical disease leishmaniasis

The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. ... Full story

Minority clinical trials participation and analysis still lag 20 years after federal mandate

UC Davis researchers urge renewed recruitment and research effort ... Full story

Pioneering stem cell therapies to be trialled in Birmingham

University of Birmingham researchers are to lead a worldwide collaboration of scientists looking at the possibility of transplanting stem cells from one person to another to reduce inflammation in the liver. ... Full story

Discrepancies in clinical trial reporting raise questions of accuracy

By Karen N. Peart - In a Yale School of Medicine analysis of 96 research trial results published in top journals, almost all had at least one discrepancy between what was reported on the public clinical trial registry clinicaltrials.gov and what was posted in the journal article. ... Full story

FDA approves lipodystrophy drug metreleptin

Follows first clinical trial led by UT Southwestern researchers ... Full story

Ethics of stem cell clinical trials

A team at the University of Exeter are contributing to the largest clinical trial of adult stem cell therapy which has started in London. This trial aims to show that the survival after a heart attack can be improved when patients are treated with their own stem cells directly after the attack. ... Full story

Patients, Researcher Await Translation of Discovery Into Clinical Trial

Whenever Xiaoyang Qi, PhD, publishes a new paper or is interviewed by the media, the e-mails arrive in clusters from all over the world. Humble, hopeful and often desperate, they come from patients and family members eager to know when Dr. Qi’s discovery – a drug that has the potential to target multiple types of cancer – will be tested in a clinical trial for people. ... Full story

FDA approves new MS treatment regimen developed at Wayne State University

Higher dose, fewer injections for patients around the world ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 485 | displaying: 1 - 10